布拉迪金宁的碳amylation作为一个机械链接受损的伤口愈合在患有功能障碍的患者
Marta Kaminska1,2, Urszula Kałucka3,4, Janka Babickova4
1Department of Microbiology, Jagiellonian University, Krakow, 30-387, Poland. marta.kaminska@uib.no.
BMC biology
|March 13, 2025
概括
碳amylation,一种常见的蛋白质修饰尿素,通过改变布拉迪基宁的功能,损害伤口愈合. 这导致组织再生延迟,并在糖尿病等疾病中造成慢性伤口.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 尿血中伤口愈合受损,但确切的原因尚不清楚.
- 碳amylation,在尿血中频繁的翻译后修改,改变蛋白质的结构和功能.
- 这项研究调查了碳amylation在-卡利克林系统对伤口愈合的影响中的作用.
研究的目的:
- 阐明碳amylation 在尿素性伤口愈合中影响基因-卡利克林系统的机制.
- 确定碳化布拉迪基宁对细胞过程的功能影响,这对于组织修复至关重要.
- 在小鼠模型中评估碳amylated bradykinin对伤口愈合的体内影响.
主要方法:
- 酶分析测量布拉迪基宁生成和碳amylation.
- 评估布拉迪基宁的受体结合亲和力和下游信号.
- 关于血管生成和状细胞迁移的体外研究.
- 在体内小鼠伤口愈合模型来评估原蛋白的生产和重新表皮化.
主要成果:
- 基尼诺基因的碳化导致异常的布拉迪基宁生成.
- 碳amylated 布拉迪基宁表现出降低的受体亲和力和B1受体和细胞因子的刺激受损.
- 碳amylated布拉迪基宁显著降低了血管生成和角质细胞的运动性.
- 在体内,碳amylated bradykinin 损害了原纤维的生产,并延迟了重新表皮化.
结论:
- 布拉迪基宁的碳amylation 是一个关键的机制,背后的受损的伤口愈合在尿血病.
- 这种由碳amylation 诱导的功能障碍有助于持续和慢性伤口,可能导致糖尿病和牛皮.
- 向碳化通路可能为改善尿素病患者的伤口愈合提供治疗策略.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
439
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
439
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Heart Failure Drugs: Diuretics
313
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
313
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K


